i
Distribution of global health measures from routinely-collected PROMIS surveys in patients with breast cancer or prostate cancer
-
December 04 2018
Source: Cancer. 125(6):943-951
Details:
-
Alternative Title:Cancer
-
Personal Author:
-
Description:Background:
The collection of patient-reported outcomes is an emerging priority internationally, guiding clinical care, quality improvement projects and research studies. Following the deployment of Patient-Reported Outcomes Measurement Information System (PROMIS) surveys in routine outpatient workflows at our academic cancer center, we used electronic health record data to evaluate survey completion rates and self-reported global health measures across two tumor types: breast and prostate cancer.
Methods:
We retrospectively analyzed 11,657 PROMIS surveys from breast cancer patients and 4,411 surveys from prostate cancer patients, calculating survey completion rates, global physical health (GPH) and global mental health (GMH) scores between 2013–2018.
Results:
A total of 36.6% of eligible breast cancer patients and 23.6% of prostate cancer patients completed at least one survey, with completion rates lower among Black patients in both tumor types (p<0.05). Mean T scores (calibrated to a general population mean of 50) for GPH were 48.4 ± 9 in breast cancer and 50.6 ± 9 in prostate cancer; and GMH scores were 52.7 ± 8 and 52.1 ± 9 respectively. GPH and GMH were frequently lower among ethnic minorities, patients without private health insurance, and those with advanced disease.
Conclusions:
Our analysis provides important baseline data on patient-reported global health in breast and prostate cancer. Demonstrating that PROs can be integrated into clinical workflows, the study shows that supportive efforts may be needed to improve PRO collection and global health endpoints in vulnerable populations.
-
Subject:
-
Source:
-
Pubmed ID:30512191
-
Pubmed Central ID:PMC6403006
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
-
File Type: